Functional impairment from monoallelic or biallelic deletions and promoter methylation is common in PTEN. In 40–50% of BC, heterozygosity loss of PTEN gene occurs, with frameshift mutations being the main cause [52, 53]. This evidence concerns the gene PTEN and breast cancer.